USA flag logo/image

An Official Website of the United States Government

Company Information:

Company Name:
INTRINSIC LIFESCIENCES, LLC
Address:
505 Coast Boulevard South
Suite 408
LA JOLLA, CA 92037-
EIN:
120441483
DUNS:
621507016
Number of Employees:
10
Woman-Owned?:
No
Minority-Owned?:
No
HUBZone-Owned?:
No

Commercialization:

Has been acquired/merged with?:
N/A
Has had Spin-off?:
N/A
Has Had IPO?:
N/A
Year of IPO:
N/A
Has Patents?:
N/A
Number of Patents:
N/A
Total Sales to Date $:
$ 0.00
Total Investment to Date $
$ 0.00
POC Title:
N/A
POC Name:
N/A
POC Phone:
N/A
POC Email:
N/A
Narrative:
N/A

Award Totals:

Program/Phase Award Amount ($) Number of Awards
SBIR Phase I $1,056,697.00 2
SBIR Phase II $1,297,387.00 1

Award List:

Serum Hepcidin Immunoassay: Laboratory to Marketplace

Award Year / Program / Phase:
2009 / SBIR / Phase I
Award Amount:
$356,360.00
Agency:
HHS
Principal Investigator:
Abstract:
DESCRIPTION (Provided by Applicant): Disorders of iron metabolism are among the most common human diseases. During the last decade, rapid progress has been made in the understanding of the molecular basis or iron homeostasis and its disorders. The peptide hormone hepcidin has emerged as the master… More

Serum Hepcidin Immunoassay: Laboratory to Marketplace

Award Year / Program / Phase:
2011 / SBIR / Phase II
Award Amount:
$1,297,387.00
Agency:
HHS
Principal Investigator:
Mark E. Westerman – 858-220-4442
Abstract:
DESCRIPTION (provided by applicant): Disorders of iron metabolism are among the most common human diseases. During the last decade, rapid progress has been made in the understanding of the molecular basis or iron homeostasis and its disorders. The peptidehormone hepcidin has emerged as the master… More

Artificial Immune Moduating (AIM??)Platform for the Treatment of Cancer

Award Year / Program / Phase:
2013 / SBIR / Phase I
Award Amount:
$700,337.00
Agency:
HHS
Principal Investigator:
Mark E. Westerman – 858-220-4442
Abstract:
DESCRIPTION (provided by applicant): Acute kidney injury (AKI) is a common, severe complication of cardiopulmonary bypass (CPB) assisted surgeries, and include coronary artery bypass grafts, valve replacements, aortic aneurisms, and organ transplants. Elderly patients, diabetics, and chronic kidney… More